Active substanceCaffeine + Paracetamol + Phenylephrine + ChlorphenamineCaffeine + Paracetamol + Phenylephrine + Chlorphenamine
Similar drugsTo uncover
  • Ajikold®
    pills inwards 
  • Rankof®
    pills inwards 
    SAVAFARM, LLC     Russia
  • Rince®
    pills inwards 
  • Rinicold
    pills inwards 
  • Dosage form: & nbspPills
    Composition:

    Each tablet contains:

    Active substances: paracetamol 500 mg; caffeine 30 mg, phenylephrine hydrochloride 10 mg, chlorpheniramine maleate 2 mg;

    Excipients: cellulose, microcrystalline 64.70 mg, starch corn 94.0 mg, gelatin 4.0 mg, povidone-KZO 5.0 mg, methyl parahydroxybenzoate 0.75 mg, propyl parahydroxybenzoate 0.075 mg, talc 15.0 mg, magnesium stearate 7.0 mg, carboxymethyl starch sodium 17.0 mg.

    Description:

    White, biconcave, oval, ns coated tablets with a risk of one side.

    ATX: & nbsp

    N.02.B.E.51   Paracetamol in combination with other drugs, excluding psycholeptics

    Pharmacodynamics:

    Combined drug. Paracetamol has antipyretic and analgeticheskoe action.

    Phenylephrine vasoconstrictive action, promoting thereby eliminating nasal congestion and reducing the discharge from the nose.

    Chlorpheniramine has antiallergic and decongestant action.Reduces permeability vessels, eliminates swelling and flushing nasal mucosa, suppresses symptoms allergic rhinitis, making breathing easier.

    Caffeine has a stimulating influence on the central nervous system, which leads to a decrease fatigue and drowsiness, to increase mental and physical working capacity.

    Pharmacokinetics:Data on the pharmacokinetics of Rinikold are not available.
    Indications:
    Contraindications:

    Hypersensitivity to components of the drug; simultaneous taking other drugs containing substances in the preparation Rinicold; simultaneous reception tricyclic antidepressants, inhibitors of MAO, beta-blockers; pregnancy, lactation; children's age (up to 6 years).

    Carefully:

    With caution in the deficiency of glucose-6-phosphate dehydrogenase; diseases of the blood, liver and / or renal failure, closed-angle glaucoma, prostate adenoma; Gilbert's syndrome, arterial hypertension, thyroid gland diseases, diabetes mellitus, bronchial asthma.

    Pregnancy and lactation:

    The drug is contraindicated for use in pregnancy and lactation (breastfeeding).

    Dosing and Administration:
    Side effects:
    Overdose:

    The drug should be taken only at recommended doses.

    Symptoms: pallor of the skin, anorexia, nausea, vomiting; hepatonecrosis; increased activity of "hepatic" transaminase, an increase in prothrombin time. In cases of overdose urgently consult a doctor.

    Treatment: gastric lavage with subsequent appointment activated carbon; symptomatic therapy.

    Interaction:
    Special instructions:

    During treatment should refrain from drinking alcohol.

    Do not take Rinicold with other drugs containing paracetamol.
    Features of the drug at the first admission or when it is canceled. No specific features of the action at the first admission or withdrawal of the drug Rinikold is not registered.
    The actions of the doctor (paramedic), the patient in the admission of taking one or more doses of Rinikold. No special action by the doctor (paramedic) or the patient while skipping one or more doses of the drug is required.

    Effect on the ability to drive transp. cf. and fur:

    Care should be taken when performing work, requiring concentrations attention, speed motor and psychomotor reactions.

    Form release / dosage:For 10 tablets in a blister of PVC-aluminum foil or in a strip of aluminum foil. For 1, 2, 3 or 4 blisters or strips with instructions for use are put in a cardboard pack.
    Packaging:
    Terms of leave from pharmacies:On prescription
    Registration number:П N014111 / 01
    Date of registration:25.11.2008
    The owner of the registration certificate:Shraya Life Senses Pvt. Ltd.Shraya Life Senses Pvt. Ltd. India
    Manufacturer: & nbsp
    Representation: & nbspSHREYA LIFE SENENSIZ Pvt.Ltd. SHREYA LIFE SENENSIZ Pvt.Ltd. India
    Information update date: & nbsp31.03.2014
    Illustrated instructions
      Instructions
      Up